[The treatment of endometriosis genitalis externa with the preparation Zoladex from the firm of Zeneca, Great Britain, combined with an immune factor in sterility--a case report].

Akusherstvo i ginekologiia · 1995 · vol. 34(1) , pp. 38–9 · PMID:7485804 · W2416241247
article OA: closed CC0
View on OpenAlex View on PubMed
AI-generated summary by qwen3.7-flash, 2026-09-21

This case report describes the treatment of external genital endometriosis and associated antisperm antibodies using the GnRH analogue Zoladex combined with methylprednisolone acetate.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is one of the main causes of female sterility, leading not only to subjective complaints, such as anovulatory menstrual cycles and LUF syndrome, but also to appearance of antisperm antibodies due to the increased number of macrophages, We present our experience in the treatment of endometriosis with the GnRH analogue Zoladex, product of Zeneca, as well as in the treatment of antisperm antibodies with methyiprednizolon acetate, Depomedrol of Upjohn.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Goserelin Immunosuppressive Agents Infertility, Female Methylprednisolone Uterine Diseases Adult Delayed-Action Preparations Drug Therapy, Combination Endometriosis Endometriosis Female Goserelin Humans Immunosuppressive Agents Infertility, Female Infertility, Female Methylprednisolone Methylprednisolone Methylprednisolone Acetate

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-21T06:08:07.822426+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:18.900538+00:00
License: CC0 · commercial use OK